Advertisement

Index by Author

October 1999; 22 (10)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abe, R

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  2. Ackerman, N R

    • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care October 1999 22:1708-1714; doi:10.2337/diacare.22.10.1708

  3. Albering, H J

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  4. Allen, H F

    • Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care October 1999 22:1703-1707; doi:10.2337/diacare.22.10.1703

  5. Ambergen, A W

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  6. Amiel, S A

    • Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care October 1999 22:1607-1611; doi:10.2337/diacare.22.10.1607

  7. Anderson, G F

    • Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care October 1999 22:1660-1666; doi:10.2337/diacare.22.10.1660

  8. Astley, S

    • Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care October 1999 22:1626-1631; doi:10.2337/diacare.22.10.1626

B

  1. Barriga, K J

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

  2. Bauer, T A

    • Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care October 1999 22:1640-1646; doi:10.2337/diacare.22.10.1640

  3. Beck, M O

    • Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care October 1999 22:1745-1747; doi:10.2337/diacare.22.10.1745a

  4. Belarbi, N

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

  5. Benjamin, E M

    • Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems. Diabetes Care October 1999 22:1672-1678; doi:10.2337/diacare.22.10.1672

  6. Bloomgarden, Z T

    • Cardiovascular disease in type 2 diabetes. Diabetes Care October 1999 22:1739-1744; doi:10.2337/diacare.22.10.1739

  7. Boyd, A S

    • Tretinoin treatment of necrobiosis lipoidica diabeticorum. Diabetes Care October 1999 22:1753-1754; doi:10.2337/diacare.22.10.1753

  8. Bradley, C

    • On calculating treatment satisfaction. Diabetes Care October 1999 22:1760; doi:10.2337/diacare.22.10.1760b

  9. Brandenburg, S L

    • Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care October 1999 22:1640-1646; doi:10.2337/diacare.22.10.1640

  10. Brooks, B

    • Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care October 1999 22:1722-1727; doi:10.2337/diacare.22.10.1722

  11. Burke, J P

    • A quantitative scale of acanthosis nigricans. Diabetes Care October 1999 22:1655-1659; doi:10.2337/diacare.22.10.1655

C

  1. Castello, E

    • Improvements in diabetic care as measured by HbA1c after a physician education project. Diabetes Care October 1999 22:1612-1616; doi:10.2337/diacare.22.10.1612

  2. Cernigoi, A M

    • Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. Diabetes Care October 1999 22:1755-1757; doi:10.2337/diacare.22.10.1755

  3. Chan, C H

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

  4. Chase, H P

    • Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care October 1999 22:1703-1707; doi:10.2337/diacare.22.10.1703
    • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care October 1999 22:1708-1714; doi:10.2337/diacare.22.10.1708

  5. Chen, R

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

  6. Classen, D C

    • Vertically transmitted enteroviruses and the benefits of neonatal immunization. Diabetes Care October 1999 22:1760-1761; doi:10.2337/diacare.22.10.1760a

  7. Classen, J B

    • Vertically transmitted enteroviruses and the benefits of neonatal immunization. Diabetes Care October 1999 22:1760-1761; doi:10.2337/diacare.22.10.1760a

  8. Clausell, N

    • Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care October 1999 22:1745-1747; doi:10.2337/diacare.22.10.1745a

  9. Coleman, K J

    • Are women with gestational diabetes more likely to have been bottle-fed? Diabetes Care October 1999 22:1747; doi:10.2337/diacare.22.10.1747b

  10. Collin, P

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

  11. Curfs, D M

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  12. Czernichow, P

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

D

  1. D'Agostino, R, Jr

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688

  2. Dahlquist, G G

    • Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care October 1999 22:1698-1702; doi:10.2337/diacare.22.10.1698

  3. Davis, W S

    • Are women with gestational diabetes more likely to have been bottle-fed? Diabetes Care October 1999 22:1747; doi:10.2337/diacare.22.10.1747b

  4. De Bellis, A

    • Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. Diabetes Care October 1999 22:1755-1757; doi:10.2337/diacare.22.10.1755

  5. Deichmann, R E

    • Improvements in diabetic care as measured by HbA1c after a physician education project. Diabetes Care October 1999 22:1612-1616; doi:10.2337/diacare.22.10.1612

  6. Dela, F

    • Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care October 1999 22:1647-1654; doi:10.2337/diacare.22.10.1647

  7. DeMacker, P N

    • Effect of troglitazone on lipoprotein(a) levels in obese subjects. Diabetes Care October 1999 22:1752-1753; doi:10.2337/diacare.22.10.1752

  8. Dunbar, V

    • Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care October 1999 22:1617-1620; doi:10.2337/diacare.22.10.1617

  9. Du Pasquier-Fediaevsky, L

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

E

  1. Edwards, A

    • Insulin lispro and retinopathy in pregnancy. Diabetes Care October 1999 22:1750-1751; doi:10.2337/diacare.22.10.1750a

  2. Eisenbarth, G S

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

  3. el-Kebbi, I M

    • Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care October 1999 22:1617-1620; doi:10.2337/diacare.22.10.1617

  4. Endo, G

    • High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care October 1999 22:1683-1687; doi:10.2337/diacare.22.10.1683

F

  1. Fermi, S J

    • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care October 1999 22:1708-1714; doi:10.2337/diacare.22.10.1708

  2. Festa, A

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688

  3. Flegal, K M

    • Blood lipid levels in type 2 diabetes. What are the effects of diet? Diabetes Care October 1999 22:1605-1606; doi:10.2337/diacare.22.10.1605

  4. Friday, K E

    • Improvements in diabetic care as measured by HbA1c after a physician education project. Diabetes Care October 1999 22:1612-1616; doi:10.2337/diacare.22.10.1612

  5. Friedman, R

    • Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care October 1999 22:1745-1747; doi:10.2337/diacare.22.10.1745a

  6. Fujii, S

    • High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care October 1999 22:1683-1687; doi:10.2337/diacare.22.10.1683

  7. Fujinuma, H

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  8. Fukui, M

    • Cellular immune response to GAD in type 1 diabetes with residual beta-cell function. Diabetes Care October 1999 22:1758-1759; doi:10.2337/diacare.22.10.1758

  9. Funae, O

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

G

  1. Galbo, H

    • Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care October 1999 22:1647-1654; doi:10.2337/diacare.22.10.1647

  2. Gallina, D L

    • Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care October 1999 22:1617-1620; doi:10.2337/diacare.22.10.1617

  3. Garg, S K

    • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care October 1999 22:1708-1714; doi:10.2337/diacare.22.10.1708

  4. Graves, P M

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

  5. Gross, J L

    • Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care October 1999 22:1745-1747; doi:10.2337/diacare.22.10.1745a

H

  1. Haffner, S M

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688

  2. Hájek, D

    • Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care October 1999 22:1745; doi:10.2337/diacare.22.10.1745b

  3. Hale, D E

    • A quantitative scale of acanthosis nigricans. Diabetes Care October 1999 22:1655-1659; doi:10.2337/diacare.22.10.1655

  4. Hales, C N

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688

  5. Harris, M I

    • Racial and ethnic differences in health insurance coverage for adults with diabetes. Diabetes Care October 1999 22:1679-1682; doi:10.2337/diacare.22.10.1679

  6. Hassan, M

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

  7. Hayashi, T

    • High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care October 1999 22:1683-1687; doi:10.2337/diacare.22.10.1683

  8. Hayward, A

    • Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care October 1999 22:1703-1707; doi:10.2337/diacare.22.10.1703

  9. Hazuda, H P

    • A quantitative scale of acanthosis nigricans. Diabetes Care October 1999 22:1655-1659; doi:10.2337/diacare.22.10.1655

  10. Heller, S R

    • Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care October 1999 22:1607-1611; doi:10.2337/diacare.22.10.1607

  11. Herold, M

    • Relationship of tumor necrosis factor-alpha plasma levels to metabolic control in type 1 diabetes. Diabetes Care October 1999 22:1749; doi:10.2337/diacare.22.10.1749

  12. Hiatt, W R

    • Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care October 1999 22:1640-1646; doi:10.2337/diacare.22.10.1640

  13. Hinchey, K T

    • Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems. Diabetes Care October 1999 22:1672-1678; doi:10.2337/diacare.22.10.1672

  14. Hirano, R

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  15. Hoffman, M R

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

  16. Hoppichler, F

    • Relationship of tumor necrosis factor-alpha plasma levels to metabolic control in type 1 diabetes. Diabetes Care October 1999 22:1749; doi:10.2337/diacare.22.10.1749

  17. Horswell, R

    • Improvements in diabetic care as measured by HbA1c after a physician education project. Diabetes Care October 1999 22:1612-1616; doi:10.2337/diacare.22.10.1612

  18. Hoshino, T

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  19. Howard, B V

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688
    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

  20. Hu, D

    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

J

  1. Jeffers, B W

    • Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care October 1999 22:1640-1646; doi:10.2337/diacare.22.10.1640

  2. Jensen, M D

    • Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. Diabetes Care October 1999 22:1728-1733; doi:10.2337/diacare.22.10.1728

  3. Jensen, P

    • Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care October 1999 22:1703-1707; doi:10.2337/diacare.22.10.1703

K

  1. Kakou, B

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

  2. Kan, E C

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

  3. Kanková, K

    • Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care October 1999 22:1745; doi:10.2337/diacare.22.10.1745b

  4. Kasuga, A

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

  5. Kaukinen, K

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

  6. Kikuchi, H

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  7. Kleinjans, J C

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  8. Klingensmith, G J

    • Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care October 1999 22:1703-1707; doi:10.2337/diacare.22.10.1703

  9. Knights, S

    • Are women with gestational diabetes more likely to have been bottle-fed? Diabetes Care October 1999 22:1747; doi:10.2337/diacare.22.10.1747b

  10. Koch, T

    • Relationship of tumor necrosis factor-alpha plasma levels to metabolic control in type 1 diabetes. Diabetes Care October 1999 22:1749; doi:10.2337/diacare.22.10.1749

  11. Ko, G T

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

  12. Koivisto, A M

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

  13. Kondo, M

    • Cellular immune response to GAD in type 1 diabetes with residual beta-cell function. Diabetes Care October 1999 22:1758-1759; doi:10.2337/diacare.22.10.1758

  14. Krop, J S

    • Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care October 1999 22:1660-1666; doi:10.2337/diacare.22.10.1660

L

  1. Lahtela, J

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

  2. Langrish-Smith, A

    • Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care October 1999 22:1626-1631; doi:10.2337/diacare.22.10.1626

  3. Larsen, J J

    • Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care October 1999 22:1647-1654; doi:10.2337/diacare.22.10.1647

  4. Lechleitner, M

    • Relationship of tumor necrosis factor-alpha plasma levels to metabolic control in type 1 diabetes. Diabetes Care October 1999 22:1749; doi:10.2337/diacare.22.10.1749

  5. Lee, E

    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

  6. Leridon, L

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

  7. Levin, S

    • Heterogeneity in associations between macronutrient intake and lipoprotein profile in individuals with type 2 diabetes. Diabetes Care October 1999 22:1632-1639; doi:10.2337/diacare.22.10.1632

M

  1. Madsbad, S

    • Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care October 1999 22:1647-1654; doi:10.2337/diacare.22.10.1647

  2. Mannucci, E

    • Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. Diabetes Care October 1999 22:1755-1757; doi:10.2337/diacare.22.10.1755

  3. Mansell, P

    • Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care October 1999 22:1607-1611; doi:10.2337/diacare.22.10.1607

  4. Marshall, J A

    • Heterogeneity in associations between macronutrient intake and lipoprotein profile in individuals with type 2 diabetes. Diabetes Care October 1999 22:1632-1639; doi:10.2337/diacare.22.10.1632

  5. Maruyama, T

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

  6. Mayer-Davis, E J

    • Heterogeneity in associations between macronutrient intake and lipoprotein profile in individuals with type 2 diabetes. Diabetes Care October 1999 22:1632-1639; doi:10.2337/diacare.22.10.1632

  7. Molyneaux, L

    • Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care October 1999 22:1722-1727; doi:10.2337/diacare.22.10.1722

  8. Morimoto, J

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

  9. Moses, R G

    • Are women with gestational diabetes more likely to have been bottle-fed? Diabetes Care October 1999 22:1747; doi:10.2337/diacare.22.10.1747b

  10. Mykkänen, L

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688

N

  1. Nakamura, N

    • Cellular immune response to GAD in type 1 diabetes with residual beta-cell function. Diabetes Care October 1999 22:1758-1759; doi:10.2337/diacare.22.10.1758

  2. Nakano, K

    • Cellular immune response to GAD in type 1 diabetes with residual beta-cell function. Diabetes Care October 1999 22:1758-1759; doi:10.2337/diacare.22.10.1758

  3. Nielsen, S

    • Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. Diabetes Care October 1999 22:1728-1733; doi:10.2337/diacare.22.10.1728

  4. Norris, J M

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

O

  1. Okada, K

    • High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care October 1999 22:1683-1687; doi:10.2337/diacare.22.10.1683

  2. Oksa, H

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

P

  1. Patterson, C

    • Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care October 1999 22:1698-1702; doi:10.2337/diacare.22.10.1698

  2. Phillips, L S

    • Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care October 1999 22:1617-1620; doi:10.2337/diacare.22.10.1617

  3. Polak, M

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

  4. Potts, R O

    • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care October 1999 22:1708-1714; doi:10.2337/diacare.22.10.1708

  5. Powe, N R

    • Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care October 1999 22:1660-1666; doi:10.2337/diacare.22.10.1660

R

  1. Reeser, H M

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  2. Regensteiner, J G

    • Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care October 1999 22:1640-1646; doi:10.2337/diacare.22.10.1640

  3. Reusch, J E

    • Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care October 1999 22:1640-1646; doi:10.2337/diacare.22.10.1640

  4. Rewers, M

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

  5. Robbins, D C

    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

  6. Rotella, C M

    • Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. Diabetes Care October 1999 22:1755-1757; doi:10.2337/diacare.22.10.1755

S

  1. Salmi, J

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

  2. Sampson, M

    • Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care October 1999 22:1626-1631; doi:10.2337/diacare.22.10.1626

  3. Saruta, T

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

  4. Saudek, C D

    • Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care October 1999 22:1660-1666; doi:10.2337/diacare.22.10.1660

  5. Schneider, M S

    • Implementing practice guidelines for diabetes care using problem-based learning. A prospective controlled trial using firm systems. Diabetes Care October 1999 22:1672-1678; doi:10.2337/diacare.22.10.1672

  6. Seino, H

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  7. Shaffer, T

    • Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care October 1999 22:1660-1666; doi:10.2337/diacare.22.10.1660

  8. Shimada, A

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

  9. Siljamäki-Ojansuu, U

    • No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care October 1999 22:1747-1748; doi:10.2337/diacare.22.10.1747a

  10. Silveiro, S P

    • Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care October 1999 22:1745-1747; doi:10.2337/diacare.22.10.1745a

  11. Simoes, E

    • Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care October 1999 22:1703-1707; doi:10.2337/diacare.22.10.1703

  12. Singer, F

    • Rethinking the diabetes prevention program clinical trial. Diabetes Care October 1999 22:1757; doi:10.2337/diacare.22.10.1757b

  13. Smits, P

    • Effect of troglitazone on lipoprotein(a) levels in obese subjects. Diabetes Care October 1999 22:1752-1753; doi:10.2337/diacare.22.10.1752

  14. Soltesz, G

    • Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care October 1999 22:1698-1702; doi:10.2337/diacare.22.10.1698

  15. Sosenko, J M

    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

  16. Southon, S

    • Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care October 1999 22:1626-1631; doi:10.2337/diacare.22.10.1626

  17. Sparling, Y H

    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

  18. Stalenhoef, A F

    • Effect of troglitazone on lipoprotein(a) levels in obese subjects. Diabetes Care October 1999 22:1752-1753; doi:10.2337/diacare.22.10.1752

  19. Stern, M P

    • A quantitative scale of acanthosis nigricans. Diabetes Care October 1999 22:1655-1659; doi:10.2337/diacare.22.10.1655

  20. Suematsu, C

    • High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care October 1999 22:1683-1687; doi:10.2337/diacare.22.10.1683

  21. Suzuki, R

    • Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function Diabetes Care 22:1759; doi:10.2337/diacare.22.10.1759

T

  1. Tack, C J

    • Effect of troglitazone on lipoprotein(a) levels in obese subjects. Diabetes Care October 1999 22:1752-1753; doi:10.2337/diacare.22.10.1752

  2. Tamada, J A

    • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care October 1999 22:1708-1714; doi:10.2337/diacare.22.10.1708

  3. Tang, J

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

  4. Tortul, C

    • Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. Diabetes Care October 1999 22:1755-1757; doi:10.2337/diacare.22.10.1755

  5. Tracy, R P

    • LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes Care October 1999 22:1688-1693; doi:10.2337/diacare.22.10.1688

  6. Tsumura, K

    • High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. The Osaka Health Survey. Diabetes Care October 1999 22:1683-1687; doi:10.2337/diacare.22.10.1683

  7. Tubiana-Rufi, N

    • Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care October 1999 22:1621-1625; doi:10.2337/diacare.22.10.1621

V

  1. Van Breda, S G

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  2. Van Maanen, J M

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  3. Vasků, A

    • Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care October 1999 22:1745; doi:10.2337/diacare.22.10.1745b

  4. Vasků, V

    • Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care October 1999 22:1745; doi:10.2337/diacare.22.10.1745b

  5. Velussi, M

    • Further data on the comparison between World Health Organization and American Diabetes Association diagnostic criteria DIAINF Study Group. Diabetes Care October 1999 22:1755-1757; doi:10.2337/diacare.22.10.1755

  6. Vibe-Petersen, J

    • Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care October 1999 22:1647-1654; doi:10.2337/diacare.22.10.1647

W

  1. Wai, H P

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

  2. Weller, W E

    • Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care October 1999 22:1660-1666; doi:10.2337/diacare.22.10.1660

  3. Welty, T

    • Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy. Diabetes Care October 1999 22:1715-1721; doi:10.2337/diacare.22.10.1715

  4. Wolffenbuttel, B H

    • Nitrate in drinking water and risk of childhood diabetes in The Netherlands. Diabetes Care October 1999 22:1750; doi:10.2337/diacare.22.10.1750b

  5. Wu, M M

    • Rapid increase in the prevalence of undiagnosed diabetes and impaired fasting glucose in asymptomatic Hong Kong Chinese. Diabetes Care October 1999 22:1751-1752; doi:10.2337/diacare.22.10.1751

Y

  1. Yamazaki, T

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  2. Yoshida, S

    • Effect of exercise training on doses of oral agents and insulin. Diabetes Care October 1999 22:1754-1755; doi:10.2337/diacare.22.10.1754

  3. Yue, D K

    • Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care October 1999 22:1722-1727; doi:10.2337/diacare.22.10.1722

  4. Yu, L

    • Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care October 1999 22:1694-1697; doi:10.2337/diacare.22.10.1694

Z

  1. Záhejský, J

    • Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care October 1999 22:1745; doi:10.2337/diacare.22.10.1745b

  2. Ziemer, D C

    • Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care October 1999 22:1617-1620; doi:10.2337/diacare.22.10.1617

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement